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EDITORIAL
Focus on Affinity Mass SpectrometryAlthough the application of affinity techniques inthe analysis of biopolymers by mass spectrom-etry has become an established approach over
the last decade or so, it is re-emerging as new method-
ology combinations and tools for the structure identifi-
cation and quantification of biopolymer interactions
become available. It can be productively used for the
identification of proteins and protein complexes from
biological material and for the enrichment and analysis
of protein structure modifications. These approaches
may be viewed as examples of “affinity mass spectrom-
etry”; they are presently developing as valuable tools
for a variety of important research areas, from identi-
fying the recognition epitopes involved in biomolecular
interactions and quantitatively determining interac-
tions, to utilizing them in personalized medicine.
This focus gives an assessment of the current state of
affinity mass spectrometry by presenting a compilation
of articles that illustrate both methods and applications.
Included are descriptions of approaches for studying
antibody-peptide epitopes and quantifying their affini-
ties, for identifying post-translational modifications, for
mapping epitopes by chemical reactions, for improving
the specificity of analytical proteomics, and for solving
problems in personalized medicine. The “marriage” of
affinity-detection techniques with the structure deter-
mination capability of MS continues to open the door to
powerful new applications in biochemistry, immunol-
ogy and biomedicine. These developments indicate that
the “marriage of affinity and MS” will provide new
information than cannot be provided by other methods,
and not by any single methodology.
We selected seven articles ranging from method
development to application to comprise this focus. In
the first article, Przybylski and coworkers report a new,
on-line bioaffinity ESI mass spectrometry instrumental
combination for examining protein/peptide and other
biopolymer interactions. The biosensor is a surface
acoustic wave device that may compete with surface
plasmon resonance, which up to now is most widely
used in investigating biomolecular interactions. The
approach allows affinity constants to be determined
and enables bioanalytical applications to the simulta-
neous, label-free determination and quantification of
biopolymer-ligand interactions as diverse as antigen-
antibody and lectin-carbohydrate complexes.
Continuing the theme of method development, De-
terding and coworkers report a useful evaluation of
several affinity resins consisting of ionic metals or metal
oxides for their capabilities to enrich for phosphopep-
tides prior to MS analysis. The authors compared
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metal media to provide a guide to select the most
efficient and specific method that can be implemented
as a standard enrichment procedure in phosphopeptide
analysis.
The next contribution reports a joint effort by the Gross
and Przybylski laboratories to adapt the PLIMSTEX
method (protein-ligand interactions by MS, titration,
and H/D exchange) to examine interactions of antibod-
ies with tyrosine- nitrated peptides, an important post-
translational modification in oxidative stress. One mo-
tivation is to conserve valuable protein material, which
is especially important when investigating large pro-
teins. Their approach is a dilution strategy whereby the
extent of H/D amide exchange of the peptide is mea-
sured as a function of diluting the original antibody/
antigen solution. The results are validated in compari-
son with data from the standard PLIMSTEX approach
and from the literature.
In the final method development contribution, the
problem of lack of robustness and reproducibility in
quantitative mass spectrometry-based proteomic assays
is addressed by Savitski, Bantscheff, and coworkers.
They describe a targeted mass spectrometric data acqui-
sition strategy for affinity enriched sub-proteomes. The
approach enables a substantially improved reproduc-
ibility of detection and improved quantification via
isobaric tags (e.g., iTRAQ). Multiple fragmentation of
the same peptides resulted in better statistics and more
precise reporter-ion-based quantification. With the tar-
geted data acquisition approach, they were able to quan-
tify more proteins and obtain higher precision than
previously.
The next contribution is a compelling example showing
the transition of method development to application.
Borchers and coworkers describe an immuno MALDI
MS-based assay of the renin-angiotensin-aldosterone sys-
tem that plays an important role in blood-pressure
regulation. Immuno-MALDI allows angiotensin I and a
stable, isotopically labeled standard peptide to be cap-
tured by taking advantage of affinity on immobilized
anti-peptide antibodies. The sample is then analyzed by
MS. The immuno MALDI assay of angiotensin I may
become a routine, rapid, and specific approach for
determining plasma rennin activity and assist in the
management of high blood pressure.
Completing the theme of applications, we present a
contribution from the Tomer group wherein they inves-
tigate a subset of the neutralizing anti-HIV antibodies
that recognize epitopes on the envelope protein of the
human immunodeficiency virus. These epitopes are
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binding. The researchers, using chemical mapping of
lysine and arginine residues and analysis by mass
spectrometry, can locate the binding epitope. More
importantly, they are able to establish that the epitope is
discontinuous.
The last contribution in the focus points clearly to
applications in personalized medicine. Glocker and
collaborators use multifactorial analysis of affinity MS
data from proteins found in serum to distinguish preg-
nant women with preeclampsia from control individu-
als. They fractionated serum proteins using affinities to
reversed-phase material coated on magnetic beads, or
by fractionated precipitation. Analysis of six protein
signals by MS showed that sorting of the individual
spectra can be achieved with high accuracy and thatpatients with preeclampsia can be distinguished rap-
idly from those who do not have the disease.
We hope that the present assembly of articles brings
useful insight into affinity mass spectrometry. This new
combination (or “hyphenated”) area will be illustrated
further by a Critical Insight of the same theme in a
subsequent issue of the journal. It is an area where
affinity measurements and approaches not only are
important in their own right, but also provide a basis
for chemical analysis, combining the specificity of affin-
ity determination with the specificity, speed, and sen-
sitivity of mass spectrometry.
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